Jean-Claude Bystryn mainly focuses on Immunology, Antibody, Vitiligo, Pemphigus and Antigen. Immunology connects with themes related to Melanoma in his study. The various areas that Jean-Claude Bystryn examines in his Antibody study include Internal medicine and Immunopathology.
His work deals with themes such as Cell, Pigmentation disorder and Melanocyte, which intersect with Vitiligo. He has included themes like Plasmapheresis, Acantholysis, Cyclophosphamide and Pemphigus vulgaris in his Pemphigus study. His Antigen study integrates concerns from other disciplines, such as Pathogenesis, Immunoprecipitation, Hair follicle, Alopecia areata and Immunofluorescence.
The scientist’s investigation covers issues in Immunology, Antibody, Antigen, Melanoma and Pathology. He combines subjects such as Pemphigus and Immunopathology with his study of Antibody. His Antigen research is multidisciplinary, incorporating elements of Molecular biology, Cell, Epidermis and Immunoprecipitation.
His work in Melanoma tackles topics such as Melanoma Vaccine which are related to areas like Vaccination. His study explores the link between Pathology and topics such as Guinea pig that cross with problems in Esophagus and Indirect immunofluorescence. His studies deal with areas such as Depigmentation, Endocrinology, Incidence, Pigmentation disorder and Melanocyte as well as Vitiligo.
His primary scientific interests are in Immunology, Dermatology, Pemphigus, Antibody and Pemphigus vulgaris. His work in Immunology is not limited to one particular discipline; it also encompasses Melanoma. The concepts of his Dermatology study are interwoven with issues in Severity of illness, Bullous pemphigoid and Disease.
His Pemphigus research integrates issues from Apoptosis, Retrospective cohort study and Immunopathology. His biological study deals with issues like Ovalbumin, which deal with fields such as T cell. His Pemphigus vulgaris research is multidisciplinary, relying on both Acantholysis, Desmoglein 3, Pathology, Desmoglein 1 and Prednisone.
His scientific interests lie mostly in Immunology, Dermatology, Disease, Pemphigus vulgaris and Pemphigus. His Immunology study frequently involves adjacent topics like Melanoma. In his study, Disease activity and Scoring system is inextricably linked to Severity of illness, which falls within the broad field of Dermatology.
He interconnects Clinical trial and Intensive care medicine in the investigation of issues within Disease. His Pemphigus vulgaris study combines topics in areas such as Desmoglein 3, Acantholysis, Pathology, Desmoglein 1 and Desmoglein. His Immunization study improves the overall literature in Antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dedee F. Murrell;Sarah Dick;A. R. Ahmed;Masayuki Amagai.
Journal of The American Academy of Dermatology (2008)
The Adjuvant Therapy of Pemphigus: An Update
Jean-Claude Bystryn;Natasha M. Steinman.
Archives of Dermatology (1996)
Prognostic significance of hypopigmentation in malignant melanoma.
Jean-Claude Bystryn;Darrell Rigel;Robert J. Friedman;Alfred Kopf.
Archives of Dermatology (1987)
Antibodies to normal human melanocytes in vitiligo.
G K Naughton;M Eisinger;J C Bystryn.
Journal of Experimental Medicine (1983)
Evidence for immunologic mechanisms in human vitiligo: Patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity
David A. Norris;R Mark. Kissinger;Gail M. Naughton;Jean Claude. Bystryn.
Journal of Investigative Dermatology (1988)
Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
Ronald Harning;Elizabeth Mainolfi;Jean-Claude Bystryn;Milagros Henn.
Cancer Research (1991)
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Dedee F. Murrell;Benjamin S. Daniel;Pascal Joly;Luca Borradori.
Journal of The American Academy of Dermatology (2012)
Patterns of remission in pemphigus vulgaris
Andrew Herbst;Jean-Claude Bystryn.
Journal of The American Academy of Dermatology (2000)
Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo
Ronald Harning;Ronald Harning;Ronald Harning;Jian Cui;Jian Cui;Jian Cui;Jean-Claude Bystryn;Jean-Claude Bystryn;Jean-Claude Bystryn.
Journal of Investigative Dermatology (1991)
REGULATION OF ANTIBODY FORMATION BY SERUM ANTIBODY : II. REMOVAL OF SPECIFIC ANTIBODY BY MEANS OF EXCHANGE TRANSFUSION
Jean-Claude Bystryn;Martin W. Graf;Jonathan W. Uhr.
Journal of Experimental Medicine (1970)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: